Way back in the queue after FDA shackles removed,
Post# of 148280
“anti-VEGF medications for wet age-related macular degeneration…”
Leronlimab downregulates VEGF, one of its anti-cancer effects as any solid tumor must build for itself a blood supply to support growth. Same principle here at work with AMD, an important cause of blindness or impaired vision.
https://apple.news/Avm1ImG6BR5GvBiImoLbZgw